We can't stress this enough: your entire study relies on the molecular integrity of your reagents
Other GLP1 receptor agonists, such as Trulicity (dulaglutide), Wegovy (also semaglutide but at a higher dose for weight loss), and Victoza (liraglutide), offer similar mechanisms but vary in dosing frequency, cost, and clinical indications
At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems
These predispositions do not determine outcomes but may contextualize why 5 units produces robust effects in some individuals and minimal response in others
The substitutions reportedly occur at the 2nd, 8th, 15th, and 27th amino acid residues, modifications thought to support stability against proteolytic degradation and improve receptor interaction
The study examined changes in depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9) and assessed suicidal ideation and behavior using the Columbia Suicide Severity Rating Scale